Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
History of pruritus of >8 weeks duration.
...
Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
History of pruritus of >8 weeks duration.
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)

Exclusion Criteria

Known poor adherence to medical recommendations
Inability to give informed consent
Any acute illness
...
Known poor adherence to medical recommendations
Inability to give informed consent
Any acute illness
Decompensated heart failure
Liver cirrhosis
Active dermatological disorder other than UP
Known allergy to Calmmax cream

Summary

Conditions
Calmmax Cream on UP in CKD Patients.
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Single Group Assignment
  • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
History of pruritus of >8 weeks duration.
...
Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
History of pruritus of >8 weeks duration.
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)

Exclusion Criteria

Known poor adherence to medical recommendations
Inability to give informed consent
Any acute illness
...
Known poor adherence to medical recommendations
Inability to give informed consent
Any acute illness
Decompensated heart failure
Liver cirrhosis
Active dermatological disorder other than UP
Known allergy to Calmmax cream

Tracking Information

NCT #
NCT02032537
Collaborators
Not Provided
Investigators
  • Principal Investigator: Itzchak Slotki, MD Shaare Zedek Medical Center
  • Itzchak Slotki, MD Shaare Zedek Medical Center